Reimbursement Support
Reimbursement Codes and Allowables
Reimbursement Guide
Patient Education
Prostate Diseases
Patient FAQs
Patient Information from Package Insert
Androgen Reduction Graph
Physician Information


  Bayer Global
  Bayer Corporate - USA
general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 
Physician Support
Patient FAQs - References		    
     
 
  1. American Cancer Society, "Cancer Resource Center: Prostate Cancer — Overview,"
    www3.cancer.org/cancerinfo/load_cont.asp?ct=36&doc=38
    &language=ENGLISH
    December 6, 2000.
  2. American Cancer Society, "Prostate Cancer Resource Center: Signs and Symptoms of Prostate Cancer,"
    www3.cancer.org/cancerinfo/load_cont.asp?st=ds&ct=36
    &language=ENGLISH
    December 6, 2000.
  3. American Cancer Society, "Cancer Resource Center: Prostate Cancer — Overview," www3.cancer.org/cancerinfo/load_cont.asp?ct=36&doc=38
    &language=ENGLISH
    December 6, 2000.
  4. American Cancer Society, "After the Tests: Prostate Cancer Survival Rates"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_3X_After_the_tests_Staging_and_grading_36?
    sitearea=CRI
  5. American Cancer Society, "What Causes Prostate Cancer?"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_2X_What_causes_prostate_cancer_36?sitearea=CRI
    October 18, 2001.
  6. American Cancer Society, "What Causes Prostate Cancer?"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_2X_What_causes_prostate_cancer_36?sitearea=CRI
    October 18, 2001.
  7. American Cancer Society, "What Causes Prostate Cancer?"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_2X_What_causes_prostate_cancer_36?sitearea=CRI
    October 18, 2001.
  8. American Cancer Society, "What Causes Prostate Cancer?"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_2X_What_causes_prostate_cancer_36?sitearea=CRI
    October 18, 2001.
  9. American Cancer Society, "What Causes Prostate Cancer?"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_2X_What_causes_prostate_cancer_36?sitearea=CRI
    October 18, 2001.
  10. American Cancer Society, "What Causes Prostate Cancer?"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_2X_What_causes_prostate_cancer_36?sitearea=CRI
    October 18, 2001.
  11. American Cancer Society, "How is Prostate Cancer Found: The Prostate Biopsy,"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_3X_How_is_prostate_cancer_found_36?sitearea=CRI
    October 18, 2001.
  12. American Cancer Society, "How is Prostate Cancer Found: Grading the Prostate Cancer,"
    http://www.cancer.org/eprise/main/docroot/CRI/content/
    CRI_2_2_3X_How_is_prostate_cancer_found_36?sitearea=CRI
    October     18, 2001.
  13. American Cancer Society, "Prostate Cancer Resource Center: The TNM Staging System,"
    www3.cancer.org/cancerinfo/loac_cont.asp?st=ds&ct=36
    &language=English
    December 6, 2000.
  14. American Cancer Society, "Prostate Cancer Resource Center: The TNM Staging System,"
    www3.cancer.org/cancerinfo/loac_cont.asp?st=ds&ct=36
    &language=English
    December 6, 2000.
  15. American Cancer Society, "Prostate Cancer Resource Center: Grading the Prostate Cancer,"
    www3.cancer.org/cancerinfo/loac_cont.asp?st=ds&ct=36
    &language=English
    December 6, 2000.
  16. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer,"
    http://www3.cancer.org/cancerinfo/load_cont.asp?ct=36
    &doc=38&language=English
    December 6, 2000.
  17. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer,"
    http://www3.cancer.org/cancerinfo/load_cont.asp?ct=36
    &doc=38&language=English
    December 6, 2000.
  18. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer,"
    http://www3.cancer.org/cancerinfo/load_cont.asp?ct=36
    &doc=38&language=English
    December 6, 2000.
  19. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer,"
    http://www3.cancer.org/cancerinfo/load_cont.asp?ct=36
    &doc=38&language=English
    December 6, 2000.
  20. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer," http://www3.cancer.org/cancerinfo/load_cont.asp?
    ct=36&doc=38&language=English
    December 6, 2000.
  21. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer,"
    http://www3.cancer.org/cancerinfo/load_cont.asp?ct=36
    &doc=38&language=English
    December 6, 2000.
  22. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer,"
    http://www3.cancer.org/cancerinfo/load_cont.asp?ct=36
    &doc=38&language=English
    December 6, 2000.
  23. American Cancer Society, "Cancer Resource Center: Treatment for Prostate Cancer,"
    http://www3.cancer.org/cancerinfo/load_cont.asp?ct=36
    &doc=38&language=English
    December 6, 2000.
 


Back

Important Safety Considerations
Viadur is contraindicated in patients with hypersensitivity to Gn-RH, Gn-RH agonist analogs, or any of the components in Viadur.

Viadur is contraindicated in women and pediatric patients and was not studied in women or children.

Viadur, like other LH-RH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience a worsening of symptoms or onset of new symptoms including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, and spinal cord compression.

The most comment systemic side effects were hot flashes (67.9%), asthenia (7.6%), gynecomastia (6.9%), depression (5.3%), and sweating (5.3%). The most common local side effects were bruising (34.6%) and burning (5.6%).

Distributed and Marketed by:
Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.